{"id":"NCT01194219","sponsor":"Amgen","briefTitle":"Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09-09","primaryCompletion":"2012-02-23","completion":"2016-11-22","firstPosted":"2010-09-02","resultsPosted":"2014-11-05","lastUpdate":"2022-03-15"},"enrollment":844,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Apremilast","otherNames":["CC-10004","Otezla"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Topical treatments or phototherapy","otherNames":["Corticosteroid creams","Light Therapy"]}],"arms":[{"label":"Apremilast","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Apremilast 30 mg","type":"ACTIVE_COMPARATOR"}],"summary":"This study evaluated the effects of an called apremilast. Apremilast works by lowering some of the chemicals that affect psoriasis and therefore improves the symptoms of psoriasis. The purpose of this study was to test apremilast and compare its effects to placebo (an inactive substance which contains no medicine but is in the same form as the drug). This study was able to test for efficacy (improvement of signs and symptoms) and safety of apremilast in patients with moderate to severe psoriasis.","primaryOutcome":{"measure":"Percentage of Participants Who Achieved a 75% Improvement (Response) in the Psoriasis Area Severity Index (PASI-75) at Week 16 From Baseline","timeFrame":"Baseline to Week 16","effectByArm":[{"arm":"Placebo/Apremilast","deltaMin":33.1,"sd":null},{"arm":"Placebo (PBO)","deltaMin":5.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["34255891","37316690"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":282},"commonTop":["Diarrhoea","Upper respiratory tract infection","Nausea","Nasopharyngitis","Tension headache"]}}